FOLD stock – Page 2

Insiders Updates

In a filing, Amicus Therapeutics Inc revealed its Director BRADLEY CAMPBELL acquired Company’s shares for reported $85650.0 on Nov 01

Insiders Updates

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Amicus Therapeutics

Analysts Viewpoint

In a filing, Amicus Therapeutics Inc revealed its President and CEO Campbell Bradley L unloaded Company’s shares for reported $79492.0

Analysts Viewpoint

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Amicus Therapeutics

Insiders Updates

Amicus Therapeutics Inc’s filing revealed that its President and CEO Campbell Bradley L unloaded Company’s shares for reported $79492.0 on

Analysts Viewpoint

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Amicus Therapeutics

Analysts Viewpoint

Amicus Therapeutics Inc’s recently made public that its President and CEO Campbell Bradley L unloaded Company’s shares for reported $79492.0

Analysts Viewpoint

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Amicus Therapeutics

Analysts Viewpoint

Amicus Therapeutics Inc’s recent filing unveils that its President and CEO Campbell Bradley L unloaded Company’s shares for reported $79492.0

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Tag: FOLD stock